Keenova Therapeutics plc Fair Value of Long-Term Debt
Keenova Therapeutics plc had Fair Value of Long-Term Debt of $3.81 billion as of 2025-09-26, per its 10-Q filed 2025-11-10.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2025-11-10
- 2025-09-26: Long-term Debt, Fair Value $3.81B.
- 2025-06-27: Long-term Debt, Fair Value $895.30M.
- 2025-03-28: Long-term Debt, Fair Value $903.50M.
- 2024-12-27: Long-term Debt, Fair Value $927.00M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2025-09-26 | $3.81B 10-Q · filed 2025-11-10 |
| 2025-06-27 | $895.30M 10-Q · filed 2025-08-06 |
| 2025-03-28 | $903.50M 10-Q · filed 2025-05-12 |
| 2024-12-27 | $927.00M 10-Q · filed 2025-11-10 |
| 2024-09-27 | $1.79B 10-Q · filed 2024-11-05 |
| 2024-06-28 | $1.79B 10-Q · filed 2024-08-06 |
| 2024-03-29 | $1.74B 10-Q · filed 2024-05-09 |
| 2023-12-29 | $1.73B 10-K · filed 2025-03-13 |
| 2023-09-29 | $2.70B 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.36B 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.63B 10-Q · filed 2023-05-09 |
| 2022-12-30 | $2.68B 10-K · filed 2024-03-26 |
| 2022-09-30 | $2.88B 10-Q · filed 2022-11-08 |
| 2022-07-01 | $3.11B 10-Q · filed 2022-08-11 |
| 2022-04-01 | $4.14B 10-Q · filed 2022-05-03 |
| 2021-12-31 | $4.27B 10-K · filed 2023-03-03 |
| 2021-09-24 | $4.41B 10-Q · filed 2021-11-02 |
| 2021-06-25 | $4.56B 10-Q · filed 2021-08-03 |
| 2021-03-26 | $4.57B 10-Q · filed 2021-05-04 |
| 2020-12-25 | $3.94B 10-K · filed 2022-03-15 |
| 2020-09-25 | $3.74B 10-Q · filed 2020-11-03 |
| 2020-06-26 | $3.27B 10-Q · filed 2020-08-04 |
| 2020-03-27 | $3.35B 10-Q · filed 2020-05-06 |
| 2019-12-27 | $3.84B 10-K · filed 2021-03-10 |
| 2019-09-27 | $3.55B 10-Q · filed 2019-11-05 |
| 2019-06-28 | $4.79B 10-Q · filed 2019-08-06 |
| 2019-03-29 | $5.36B 10-Q · filed 2019-05-07 |
| 2018-12-28 | $5.27B 10-K · filed 2020-02-26 |
| 2018-09-28 | $5.92B 10-Q · filed 2018-11-06 |
| 2018-06-29 | $5.95B 10-Q · filed 2018-08-07 |
| 2017-12-29 | $6.35B 10-K · filed 2019-02-26 |